NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells
2020 · Signal Transduction and Targeted Therapy · 33 citations
https://doi.org/10.1038/s41392-019-0102-5
F
Fabı́ola Traina
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
351
Papers
4.3K
Citations
35
h-index
97
i10-index
Fabı́ola Traina is an academic researcher from Misurata University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 35, co-authored 299 publications.
ORCID: 0000-0003-4258-289XPapers by this author
worksMetformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
2018 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-017-0256-4
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
2012 · Journal of Hematology & Oncology · 26 citations
https://doi.org/10.1186/1756-8722-5-4
Identification of protein-coding and non-coding RNA expression profiles in CD34+and in stromal cells in refractory anemia with ringed sideroblasts
2010 · BMC Medical Genomics · 21 citations
https://doi.org/10.1186/1755-8794-3-30
Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies
2024 · MUSCULOSKELETAL SURGERY · 8 citations
https://doi.org/10.1007/s12306-024-00827-z
Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia
2024 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-024-74168-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat